80 related articles for article (PubMed ID: 21795067)
1. Inflammatory response to recombinant human bone morphogenetic protein-2 use in the treatment of a proximal humeral fracture: a case report.
Julka A; Shah AS; Miller BS
J Shoulder Elbow Surg; 2012 Jan; 21(1):e12-6. PubMed ID: 21795067
[No Abstract] [Full Text] [Related]
2. Outcome of nonunion fractures in dogs treated with fixation, compression resistant matrix, and recombinant human bone morphogenetic protein-2.
Massie AM; Kapatkin AS; Fuller MC; Verstraete FJ; Arzi B
Vet Comp Orthop Traumatol; 2017 Mar; 30(2):153-159. PubMed ID: 28094415
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human bone morphogenetic protein-2 use in the off-label treatment of nonunions and acute fractures: a retrospective review.
Starman JS; Bosse MJ; Cates CA; Norton HJ
J Trauma Acute Care Surg; 2012 Mar; 72(3):676-81. PubMed ID: 22491552
[TBL] [Abstract][Full Text] [Related]
4. Application of recombinant BMP-7 on persistent upper and lower limb non-unions.
Dimitriou R; Dahabreh Z; Katsoulis E; Matthews SJ; Branfoot T; Giannoudis PV
Injury; 2005 Nov; 36 Suppl 4():S51-9. PubMed ID: 16291324
[TBL] [Abstract][Full Text] [Related]
5. Clinical use of recombinant human bone morphogenic protein-2 in a whooping crane (Grus americana).
Sample S; Cole G; Paul-Murphy J; Hartup BK; Clyde V; Seeherman HJ; Schaefer S
Vet Surg; 2008 Aug; 37(6):552-7. PubMed ID: 19134105
[TBL] [Abstract][Full Text] [Related]
6. [High bone consolidation rates after humeral head-preserving revision surgery in non-unions of the proximal humerus].
Aytac SD; Schnetzke M; Hudel I; Studier-Fischer S; Grützner PA; Gühring T
Z Orthop Unfall; 2014 Dec; 152(6):596-602. PubMed ID: 25531521
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human bone morphogenetic protein-2 in open tibial fractures. A subgroup analysis of data combined from two prospective randomized studies.
Swiontkowski MF; Aro HT; Donell S; Esterhai JL; Goulet J; Jones A; Kregor PJ; Nordsletten L; Paiement G; Patel A
J Bone Joint Surg Am; 2006 Jun; 88(6):1258-65. PubMed ID: 16757759
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of recombinant human bone morphogenetic protein-2/calcium phosphate matrix for closed tibial diaphyseal fracture: a double-blind, randomized, controlled phase-II/III trial.
Lyon T; Scheele W; Bhandari M; Koval KJ; Sanchez EG; Christensen J; Valentin A; Huard F
J Bone Joint Surg Am; 2013 Dec; 95(23):2088-96. PubMed ID: 24306695
[TBL] [Abstract][Full Text] [Related]
9. The use of allograft and recombinant human bone morphogenetic protein for instrumented atlantoaxial fusions.
Hood B; Hamilton DK; Smith JS; Dididze M; Shaffrey C; Levi AD
World Neurosurg; 2014 Dec; 82(6):1369-73. PubMed ID: 23336983
[TBL] [Abstract][Full Text] [Related]
10. Bone morphogenetic proteins in open fractures: past, present, and future.
Nauth A; Ristiniemi J; McKee MD; Schemitsch EH
Injury; 2009 Dec; 40 Suppl 3():S27-31. PubMed ID: 20082787
[TBL] [Abstract][Full Text] [Related]
11. No advantage to rhBMP-2 in addition to autogenous graft for fracture nonunion.
Takemoto R; Forman J; Taormina DP; Egol KA
Orthopedics; 2014 Jun; 37(6):e525-30. PubMed ID: 24972432
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human bone morphogenetic proteins in the treatment of fractures.
Kain MS; Einhorn TA
Foot Ankle Clin; 2005 Dec; 10(4):639-50, viii. PubMed ID: 16297824
[TBL] [Abstract][Full Text] [Related]
13. Timing of surgery for open reduction and internal fixation of displaced proximal humeral fractures.
Siebenbürger G; Van Delden D; Helfen T; Haasters F; Böcker W; Ockert B
Injury; 2015 Oct; 46 Suppl 4():S58-62. PubMed ID: 26542867
[TBL] [Abstract][Full Text] [Related]
14. Arthroscopically assisted minimally invasive plate osteosynthesis for posterior fracture-dislocation of the shoulder.
Fukuda A; Nishimura A; Kato K; Sudo A
J Orthop Sci; 2014 Jan; 19(1):194-7. PubMed ID: 23053580
[No Abstract] [Full Text] [Related]
15. [A comparative study between humeral head prosthesis replacement and internal fixation for treatment of comminuted proximal humeral fractures].
Wu H; Cha ZG; Lin HS; Hou HG; Feng YH; Li JR
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Mar; 30(3):560-4. PubMed ID: 20335139
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of routine use of recombinant human bone morphogenetic protein-2 in occipitocervical and atlantoaxial fusions of the pediatric spine: a minimum of 12 months' follow-up with computed tomography.
Sayama C; Hadley C; Monaco GN; Sen A; Brayton A; Briceño V; Tran BH; Ryan SL; Luerssen TG; Fulkerson D; Jea A
J Neurosurg Pediatr; 2015 Jul; 16(1):14-20. PubMed ID: 25860982
[TBL] [Abstract][Full Text] [Related]
17. The results of ORIF of displaced unstable proximal humeral fractures using a locking plate.
Duralde XA; Leddy LR
J Shoulder Elbow Surg; 2010 Jun; 19(4):480-8. PubMed ID: 19963400
[TBL] [Abstract][Full Text] [Related]
18. Acceleration of second and fourth metatarsal fracture healing with recombinant human bone morphogenetic protein-2/calcium phosphate cement in horses.
Perrier M; Lu Y; Nemke B; Kobayashi H; Peterson A; Markel M
Vet Surg; 2008 Oct; 37(7):648-55. PubMed ID: 19134087
[TBL] [Abstract][Full Text] [Related]
19. Ultra-low-dose recombinant human bone morphogenetic protein-2 for 3-level anterior cervical diskectomy and fusion.
Pourtaheri S; Hwang K; Faloon M; Issa K; Mease SJ; Mangels D; Sinha K; Emami A
Orthopedics; 2015 Apr; 38(4):241-5. PubMed ID: 25901613
[TBL] [Abstract][Full Text] [Related]
20. BMP-2 delivered from a self-crosslinkable CaP/hydrogel construct promotes bone regeneration in a critical-size segmental defect model of non-union in dogs.
Minier K; Touré A; Fusellier M; Fellah B; Bouvy B; Weiss P; Gauthier O
Vet Comp Orthop Traumatol; 2014; 27(6):411-21. PubMed ID: 25327869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
